Seasonal affective disorders is a form of recurrent depression that appears to be precipitated by a specific stressor (i.e., winter) and resolves spontaneously in spring or summer. The elements of winter that must contribute to SAD are unknown at this time although light deficiency most likely plays a role. It is similar to late luteal dysphoric disorder because of the circumscribed time course, range of severity and female predominance. Atypical anergic symptoms usually dominate the clinical picture but more typical anxious and agitated symptoms can be present. Onset and offset of symptoms and severity varies greatly. Fall onset is usually gradual while spring remission can be more startling and abrupt producing hypomania in some patients. Full summer remission occurs in most patients when followed prospectively and is associated with improvement in personality and biological measures. Most patients improve with light therapy but it is not known how sustained this effect is or whether it is comparable to treatment with antidepressants in similarly affected patients. BL treatment also implies a single etiological mechanism of SAD, but this is still unproven. Lights, while effective do not appear to be as effective as summer. This could be because most BL clinical trials have been too brief to actually simulate summer or because of the significant heterogeneity in population. It is important to remember that lights alone cannot replicate summer conditions. Summer light is up to ten times stronger than currently available light boxes and the season produces many other environmental and social changes. Most likely SAD will prove similar to other forms of depression in that it is a multidimensional problem which requires a variety of treatments to alleviate various aspects of the syndrome.
Download full-text PDF |
Source |
---|
Indian J Psychiatry
November 2024
Department of Psychiatry, Murshidabad Medical College and Hospital, Murshidabad, West Bengal, India.
Background: There is lack of data on bipolar disorder (BD) type II from India.
Aim: To compare the demographic and clinical characteristics of patients with BD-I and BD-II using the data of the Bipolar Disorder Course and Outcome study from India (BiD-CoIN study).
Methodology: Using the data of the BiD-CoIN study, patients with BD-I and BD-II were compared for demographic and clinical variables.
Cureus
December 2024
Psychiatry, Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, IND.
Psychiatry Res
December 2024
Département de psychiatrie et d'addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hôpital Bichat - Claude Bernard, F-75018 Paris, France; Université Paris Cité, NeuroDiderot, Inserm, FHU I2-D2, F-75019 Paris, France; Centre ChronoS, GHU Paris - Psychiatrie & Neurosciences, 1 rue Cabanis, 75014 Paris, France; CNRS UPR 3212 & Strasbourg University, Institute for Cellular and Integrative Neurosciences, F-67000, Strasbourg, France. Electronic address:
Depressive disorders are characterized by disturbances in light signal processing. More specifically, an alteration of the melanopsin response is suggested. The post-illumination pupillary response (PIPR) to blue light (post-blue PIPR) is increasingly used as a marker of the activity of intrinsically photosensitive melanopsin ganglion cells (ipRGCs).
View Article and Find Full Text PDFPLoS One
December 2024
Department Learning Informatics Management and Ethics, Medical Management Centre, Karolinska Institutet, Stockholm, Sweden.
Trends in health, well-being, stress and the psychosocial work environment were studied using repeated measurements over time. The role of health-relevant personality in predicting development over time and typical ratings was also assessed. 517 individuals were included.
View Article and Find Full Text PDFMed Sci Monit
November 2024
II Department of Psychiatry and Psychiatric Rehabilitation, Medical University of Lublin, Lublin, Poland.
Depression affects about 280 million people globally and is marked by persistent sadness and impaired daily functioning. Sleep disturbances are prevalent in major depressive disorder, affecting roughly 90% of patients, and are linked to the severity and progression of depression. This review emphasizes the critical role of sleep in depressive disorders and evaluates the alternative treatments bright light therapy and sleep deprivation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!